Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
rb2fA3AanD8C95wq
